BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 28162942)

  • 1. Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
    Kang M; Balpukov UJ; Jeong CW; Kwak C; Kim HH; Ku JH
    Clin Genitourin Cancer; 2017 Jun; 15(3):e411-e420. PubMed ID: 28162942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretreatment neutrophil-to-lymphocyte ratio is associated with advanced pathologic tumor stage and increased cancer-specific mortality among patients with urothelial carcinoma of the bladder undergoing radical cystectomy.
    Viers BR; Boorjian SA; Frank I; Tarrell RF; Thapa P; Karnes RJ; Thompson RH; Tollefson MK
    Eur Urol; 2014 Dec; 66(6):1157-64. PubMed ID: 24630414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of neutrophil-to-lymphocyte ratio and establishment of novel preoperative risk stratification model in bladder cancer patients treated with radical cystectomy.
    Gondo T; Nakashima J; Ohno Y; Choichiro O; Horiguchi Y; Namiki K; Yoshioka K; Ohori M; Hatano T; Tachibana M
    Urology; 2012 May; 79(5):1085-91. PubMed ID: 22446338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative neutrophil-lymphocyte ratio can significantly predict mortality outcomes in patients with non-muscle invasive bladder cancer undergoing transurethral resection of bladder tumor.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Oncotarget; 2017 Feb; 8(8):12891-12901. PubMed ID: 28039452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NLR is predictive of upstaging at the time of radical cystectomy for patients with urothelial carcinoma of the bladder.
    Potretzke A; Hillman L; Wong K; Shi F; Brower R; Mai S; Cetnar JP; Abel EJ; Downs TM
    Urol Oncol; 2014 Jul; 32(5):631-6. PubMed ID: 24629498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophil-to-lymphocyte ratio as a detection marker of tumor recurrence in patients with muscle-invasive bladder cancer after radical cystectomy.
    Morizawa Y; Miyake M; Shimada K; Hori S; Tatsumi Y; Nakai Y; Anai S; Tanaka N; Konishi N; Fujimoto K
    Urol Oncol; 2016 Jun; 34(6):257.e11-7. PubMed ID: 27038696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Prognostic Significance of the Early Postoperative Neutrophil-to-Lymphocyte Ratio in Patients with Urothelial Carcinoma of the Bladder Undergoing Radical Cystectomy.
    Kang M; Jeong CW; Kwak C; Kim HH; Ku JH
    Ann Surg Oncol; 2016 Jan; 23(1):335-42. PubMed ID: 26152275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of routine preoperative blood parameters in muscle-invasive bladder cancer.
    Zhang J; Zhou X; Ding H; Wang L; Liu S; Liu Y; Chen Z
    BMC Urol; 2020 Mar; 20(1):31. PubMed ID: 32192483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenia as a Novel Preoperative Prognostic Predictor for Survival in Patients with Bladder Cancer Undergoing Radical Cystectomy.
    Hirasawa Y; Nakashima J; Yunaiyama D; Sugihara T; Gondo T; Nakagami Y; Horiguchi Y; Ohno Y; Namiki K; Ohori M; Tokuuye K; Tachibana M
    Ann Surg Oncol; 2016 Dec; 23(Suppl 5):1048-1054. PubMed ID: 27699608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of perioperative lymphocyte-monocyte ratio in patients with bladder cancer undergoing radical cystectomy.
    Yoshida T; Kinoshita H; Yoshida K; Mishima T; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Fukui K; Harada J; Kawa G; Matsuda T
    Tumour Biol; 2016 Aug; 37(8):10067-74. PubMed ID: 26819209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancer.
    Matsumoto A; Nakagawa T; Kanatani A; Ikeda M; Kawai T; Miyakawa J; Taguchi S; Naito A; Otsuka M; Nakanishi Y; Suzuki M; Koga F; Nagase Y; Kondo Y; Okaneya T; Tanaka Y; Miyazaki H; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    World J Urol; 2018 Feb; 36(2):249-256. PubMed ID: 29185045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy.
    Kawahara T; Furuya K; Nakamura M; Sakamaki K; Osaka K; Ito H; Ito Y; Izumi K; Ohtake S; Miyoshi Y; Makiyama K; Nakaigawa N; Yamanaka T; Miyamoto H; Yao M; Uemura H
    BMC Cancer; 2016 Mar; 16():185. PubMed ID: 26944862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy.
    Zhang GM; Zhu Y; Luo L; Wan FN; Zhu YP; Sun LJ; Ye DW
    Tumour Biol; 2015 Nov; 36(11):8537-43. PubMed ID: 26032095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts for Good Outcomes in Patients Receiving Neoadjuvant Chemotherapy Before Radical Cystectomy for Muscle Invasive Bladder Cancer.
    Buisan O; Orsola A; Areal J; Font A; Oliveira M; Martinez R; Ibarz L
    Clin Genitourin Cancer; 2017 Feb; 15(1):145-151.e2. PubMed ID: 27364982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel risk stratification model, involving preoperative lymphocyte-monocyte ratio and standard pathological factors, for overall survival in patients with bladder cancer undergoing radical cystectomy.
    Yoshida T; Kinoshita H; Yoshida K; Yanishi M; Inui H; Komai Y; Sugi M; Inoue T; Murota T; Matsuda T
    Jpn J Clin Oncol; 2015 Dec; 45(12):1162-7. PubMed ID: 26423342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative Prognostic Nutritional Index is a Significant Predictor of Survival with Bladder Cancer after Radical Cystectomy: a retrospective study.
    Peng D; Gong YQ; Hao H; He ZS; Li XS; Zhang CJ; Zhou LQ
    BMC Cancer; 2017 Jun; 17(1):391. PubMed ID: 28578683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment neutrophil-to-lymphocyte ratio as predictor of adverse outcomes in patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Hermanns T; Bhindi B; Wei Y; Yu J; Noon AP; Richard PO; Bhatt JR; Almatar A; Jewett MA; Fleshner NE; Zlotta AR; Templeton AJ; Kulkarni GS
    Br J Cancer; 2014 Jul; 111(3):444-51. PubMed ID: 24918819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocyte-to-monocyte ratio and neutrophil-to-lymphocyte ratio as biomarkers for predicting lymph node metastasis and survival in patients treated with radical cystectomy.
    D'Andrea D; Moschini M; Gust KM; Abufaraj M; Özsoy M; Mathieu R; Soria F; Briganti A; Rouprêt M; Karakiewicz PI; Shariat SF
    J Surg Oncol; 2017 Mar; 115(4):455-461. PubMed ID: 28105663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Preoperative Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios in Bladder Cancer Patients Undergoing Radical Cystectomy.
    Wang R; Yan Y; Liu S; Yao X
    Biomed Res Int; 2019; 2019():3628384. PubMed ID: 31662975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the best complete blood count-based predictors for bladder cancer outcomes in patients undergoing radical cystectomy.
    Bhindi B; Hermanns T; Wei Y; Yu J; Richard PO; Wettstein MS; Templeton A; Li K; Sridhar SS; Jewett MA; Fleshner NE; Zlotta AR; Kulkarni GS
    Br J Cancer; 2016 Jan; 114(2):207-12. PubMed ID: 26657651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.